Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1988 1
1989 3
1990 1
1993 2
1994 2
1996 2
1997 1
1998 2
1999 1
2000 1
2002 4
2003 6
2004 11
2005 7
2006 14
2007 11
2008 6
2009 20
2010 15
2011 12
2012 17
2013 16
2014 14
2015 16
2016 17
2017 24
2018 23
2019 19
2020 17
2021 14
2022 20
2023 14
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial.
Mei WJ, Wang XZ, Li YF, Sun YM, Yang CK, Lin JZ, Wu ZG, Zhang R, Wang W, Li Y, Zhuang YZ, Lei J, Wan XB, Ren YK, Cheng Y, Li WL, Wang ZQ, Xu DB, Mo XW, Ju HX, Ye SW, Zhao JL, Zhang H, Gao YH, Zeng ZF, Xiao WW, Zhang XP, Zhang X, Xie E, Feng YF, Tang JH, Wu XJ, Chen G, Li LR, Lu ZH, Wan DS, Bei JX, Pan ZZ, Ding PR. Mei WJ, et al. Among authors: pan zz. Ann Surg. 2023 Apr 1;277(4):557-564. doi: 10.1097/SLA.0000000000005780. Epub 2022 Dec 20. Ann Surg. 2023. PMID: 36538627 Free PMC article. Clinical Trial.
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study.
Chen G, Jin Y, Guan WL, Zhang RX, Xiao WW, Cai PQ, Liu M, Lin JZ, Wang FL, Li C, Quan TT, Xi SY, Zhang HZ, Pan ZZ, Wang F, Xu RH. Chen G, et al. Among authors: pan zz. Lancet Gastroenterol Hepatol. 2023 May;8(5):422-431. doi: 10.1016/S2468-1253(22)00439-3. Epub 2023 Mar 1. Lancet Gastroenterol Hepatol. 2023. PMID: 36870360 Clinical Trial.
Comprehensive profiling of 1015 patients' exomes reveals genomic-clinical associations in colorectal cancer.
Zhao Q, Wang F, Chen YX, Chen S, Yao YC, Zeng ZL, Jiang TJ, Wang YN, Wu CY, Jing Y, Huang YS, Zhang J, Wang ZX, He MM, Pu HY, Mai ZJ, Wu QN, Long R, Zhang X, Huang T, Xu M, Qiu MZ, Luo HY, Li YH, Zhang DS, Jia WH, Chen G, Ding PR, Li LR, Lu ZH, Pan ZZ, Xu RH. Zhao Q, et al. Among authors: pan zz. Nat Commun. 2022 Apr 29;13(1):2342. doi: 10.1038/s41467-022-30062-8. Nat Commun. 2022. PMID: 35487942 Free PMC article.
Transcriptional control of Gad2.
Pan ZZ. Pan ZZ. Transcription. 2012 Mar-Apr;3(2):68-72. doi: 10.4161/trns.19511. Epub 2012 Mar 1. Transcription. 2012. PMID: 22414751 Free PMC article. Review.
TDO as a therapeutic target in brain diseases.
Yu CP, Pan ZZ, Luo DY. Yu CP, et al. Among authors: pan zz. Metab Brain Dis. 2016 Aug;31(4):737-47. doi: 10.1007/s11011-016-9824-z. Epub 2016 Apr 13. Metab Brain Dis. 2016. PMID: 27072164 Review.
Expert opinions on immunotherapy for patients with colorectal cancer.
Wang F, Wang ZX, Chen G, Luo HY, Zhang DS, Qiu MZ, Wang DS, Pan ZZ, Shen L, Li J, Zhang SZ, Xu RH. Wang F, et al. Among authors: pan zz. Cancer Commun (Lond). 2020 Oct;40(10):467-472. doi: 10.1002/cac2.12095. Epub 2020 Sep 18. Cancer Commun (Lond). 2020. PMID: 32945625 Free PMC article. No abstract available.
314 results